CODX Co-Diagnostics Inc: ערך חשבונאי למניה

The potential of Co-Diagnostics, Inc. (CODX) is based on the automation of PCR assays, which eliminates manual labor. The book value per common share clearly demonstrates asset dynamics, with the value stabilizing at 2.60. However, sales are constrained by US and Chinese trade barriers, while falling demand for tests forces the company to compete aggressively for market share against major players.

To objectively assess the stability of Co-Diagnostics, Inc. (CODX), it is critical for a portfolio manager to calculate the net asset value per share, which measures the real value of the business's tangible assets and reserves. By analyzing the trend of the book value per share, an investor can track the accumulation of resources, which in this case is supported by the localization of production in the US and the optimization of reagent logistics to minimize external shocks.